PMTI Palomar Medical Technologies, Inc. (MM)

Palomar Launches New Light-Based System BURLINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Palomar Medical Technologies Inc announced the introduction of it's next generation pulsed-light and laser system, the Palomar StarLux(TM), this past weekend at the American Academy of Dermatology's (AAD) 62nd Annual Meeting in Washington, DC. The StarLux includes all of the pulsed light handpieces available on prior Palomar pulsed light systems plus the new Lux1064 YAG laser handpiece to treat vascular lesions including leg veins. The Palomar StarLux pulsed-light and laser system is computer controlled for easy operation and provides physicians with an adjustable "smooth pulse" energy output and integrated contact cooling at the sapphire tip for addedsafety and patient comfort. Optimum spectrum selection plus higher power and fast repetition rate have been incorporated into this ultra-compact pulsed light design to rival the performance of much higher priced, single application laser technology. Like the MediLux(TM), EsteLux(TM) and NeoLux(TM) systems, the StarLux has many versatile handpieces that can be used for the removal of hair, treatment of acne (pending FDA clearance) and for photofacial applications for the treatment of pigmented and vascular lesions to improve skin tone and texture. In addition, the StarLux has the new Lux1064 YAG laser handpiece to treat vascular lesions including leg veins. Chief Executive Officer Joseph P. Caruso commented, "Palomar came to this year's AAD meeting feeling invigorated having just announced the Company's outstanding financial results for the calendar year ended 2003 as well as earlier in 2003 announcing a major strategic agreement with The Gillette Company (NYSE:G) to complete development and commercialize a patented home- use, light-based hair removal device for women. Along with this momentum, we were able to announce at the AAD the next generation Lux system. Needless to say, we believe 2004 will be a very exciting year for Palomar." Caruso continued, "Palomar is proud of its continued improvement to the Lux system platform. Palomar has kept its commitment to continually provide value to customers who invest in our Lux system platform. The StarLux, MediLux, EsteLux and NeoLux systems are the most affordable and versatile cosmetic light-based systems on the market. The Lux platform enables us to custom tailor our products to fit almost any professional medical office or spa location. These systems offer a suite of applications ata fraction of the cost of other competing systems." Chief Financial Officer Paul S. Weiner commented, "We have recently completed a very successful investor relation's roadshow at the AAD where we met with managers of numerous investment funds and analysts to discuss Palomar's strategic initiative and growth potential. The tremendous interest generated in Palomar through these meetings is not surprising given the recent financial results and successful implementation of our overall business strategy. We look forward to continued positive meetings with investors and fund managers in 2004." About Palomar Medical Technologies Inc: Palomar is a leading researcher and developer of light-based systems for hair removal and other cosmetic treatments. In 2003, Palomar and The Gillette Company (NYSE:G) entered into an agreement to complete development and commercialize a patented home-use, light-based hair removal device for women. New and exciting indications are being tested to further advance the hair removal market and other cosmetic applications. Palomar pioneered the optical hair removal field, when, in 1996, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. There are now millions of light-based hair removal procedures performed around the world every year in physician offices, clinics, spas and salons. For more information on Palomar and its products, visit Palomar's website at http://www.palomarmedical.com/. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the E-mail Alerts page in the Investor Relations section ofthe website. With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements, including but not limited to statements relating to new markets, development and introduction of new products, and financial projections that involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performance to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will beobtained for future products, the results of litigation, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2002 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. TheCompany undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Contacts: Paul S. Weiner Chief Financial Officer Palomar Medical Technologies Inc 781-993-2411 DATASOURCE: Palomar Medical Technologies Inc CONTACT: Paul S. Weiner, Chief Financial Officer of Palomar Medical Technologies Inc, +1-781-993-2411, Web site: http://www.palmed.com/ Company News On-Call: http://www.prnewswire.com/comp/107555.html

Copyright